Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06698263 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

13-cis Retinoic Acid (Isotretinoin) and Sperm Production

Name: 13-cis Retinoic Acid (Isotretinoin) and Sperm Production — clinical trial record (NCT06698263)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: ARESPERM

StatusNot Yet Recruiting

PhasePhase 4

SponsorUniversity Hospital, Strasbourg, France

Started2025-03-01

View on ClinicalTrials.gov ↗

Amendment history

2024-11-21

Study Status, Outcome Measures v1

Re-verified, no change to tracked fields

2024-11-18

Original filing

University Hospital, Strasbourg, France

315 trials monitored

See 7 trials at risk

This study aims to evaluate the effectiveness of weekly administration of isotretinoin (40 mg) in increasing sperm production in men with oligozoospermia, a condition characterized by a low sperm count. Participants will be randomized into two groups: one receiving isotretinoin and the other a placebo. The primary outcome will be the change in sperm production over 20 weeks of treatment.

Trial Details

NCT Number	NCT06698263
Lead Sponsor	University Hospital, Strasbourg, France
Conditions	Men with Infertility
Enrollment	100 participants
Start Date	2025-03-01
Primary Completion	2027-12-01 (estimated)
Study Completion	2027-12-01 (estimated)
Updated on ClinicalTrials.gov	2024-11-25